Optinose to Announce Third Quarter Financial Results
Optinose (NASDAQ:OPTN), a notable player in the pharmaceutical arena, particularly focusing on treatments recommended by ear, nose, and throat (ENT) specialists, has made a significant announcement. The company is gearing up to report its financial results for the third quarter of 2024. This report, along with crucial corporate updates, is expected to be unveiled just before the market opens on the upcoming Tuesday.
Details on the Reporting Schedule
The anticipated financial disclosures will be revealed on November 12, 2024. Investors and stakeholders alike are anxious to gain insights into the company’s performance and outlook, as well as updates from their leadership team.
Conference Call for Investors
In conjunction with the financial results, Optinose will also host a conference call dedicated to discussing these results in detail. This call is scheduled to start at 8:00 a.m. Eastern Time on the same day. Participants will have the opportunity to gain valuable information directly from the company’s leadership and ask questions about the specifics of the financial performance.
How to Join the Conference Call
Interested participants can access the conference call live through a webcast that will be available in the Investors section of the Optinose website. For those preferring a telephone option, prior registration will be required. Once registered, participants will receive a confirmation email which includes details about how to join the call, including the required dial-in number and a personal PIN. Additionally, Optinose will provide a replay of the webcast on their site for 60 days, making it accessible for those who may not be able to join live.
About Optinose
Optinose is a specialty pharmaceutical company dedicated to enhancing the lives of patients under the care of ENT and allergy specialists. With a focus on innovative treatments, the company is committed to addressing the diverse needs of these patients. For more information about their product offerings and corporate initiatives, potential customers and investors are encouraged to visit their corporate website and follow their updates on social media platforms.
Connect with Optinose
Optinose is active on various social media platforms, allowing stakeholders to stay updated on their latest news and developments. Engaging with their content online can provide further insights into their strategies and upcoming initiatives.
Optinose Investor Contact Information
For further inquiries, investors and the media can reach out to Jonathan Neely at Optinose. He is available via email at jonathan.neely@optinose.com or by phone at 267.521.0531. This contact point is crucial for those requiring additional information or wishing to delve deeper into Optinose's operations and future plans.
Frequently Asked Questions
What date will Optinose announce their financial results?
Optinose will announce their third quarter financial results on November 12, 2024.
How can I participate in the conference call?
To participate in the conference call, you can register in advance via the Optinose website or join the live webcast available during the event.
What is the focus of Optinose as a company?
Optinose primarily focuses on serving patients treated by ear, nose, and throat (ENT) specialists and allergy experts.
Is there a way to replay the conference call?
Yes, a replay of the conference call will be available on the Optinose website for 60 days after the event.
Who should I contact for investor relations?
You can contact Jonathan Neely at jonathan.neely@optinose.com for any investor relations inquiries.